Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) EBIT Growth (1y) (2010 - 2026)

Analysis

Quest Diagnostics (DGX) EBIT Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 31.33%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 4.79%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 14.47%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn -21.34%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -22.89%
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn 249.68%
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 12.36%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn 438.23%
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 37.01%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 86.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.79%
Mar 31, 2026 15.32%
Dec 31, 2025 6.93%
Sep 30, 2025 16.97%
Jun 30, 2025 23.38%
Mar 31, 2025 15.33%
Dec 31, 2024 35.21%
Sep 30, 2024 -3.51%
Jun 30, 2024 2.01%
Mar 31, 2024 -1.64%
Dec 31, 2023 97.78%
Sep 30, 2023 -12.76%
Jun 30, 2023 -10.31%
Mar 31, 2023 -40.55%
Dec 31, 2022 -74.81%
Sep 30, 2022 -39.88%
Jun 30, 2022 -27.20%
Mar 31, 2022 -22.27%
Dec 31, 2021 -32.58%
Sep 30, 2021 -9.19%